|
Dendritic Nanotechnologies Inc. (DNT), a technology company that develops advanced dendritic polymers used to produce commercial products, today announced that Priostar™ dendrimers are available on a limited basis to the commercial sector. This new product line of nanoscale building blocks represents a year-long effort by DNT to drive down the manufacturing costs associated with nanotechnology, and to refine the technology for mass-market commercialisation.
DNT is exhibiting in Booth 584 at this year’s National Plastics Exhibition to introduce Priostar to the plastics community and to demonstrate how nanotechnology can be harnessed by materials manufacturers as they address new market opportunities.
“The National Plastics Exhibition comes at a perfect time for DNT as we are ramping up our production on Priostar,” said Ryan Hayes, DNT’s director of business development. “We are eager to work with scientists in the industrial sector who are wrestling with complex formulation and manufacturing problems. We believe we can solve many of these with our Priostar dendrimers and provide them with alternatives to ground-down nanoparticles.”
Priostar dendrimers represent the synergistic combination of polymers with nanotechnology. They are a part of the fourth class of polymer architectures defined as dendritic polymers. The nanoscale size and dendritic (or highly branched) nature of these precision polymeric nanostructures provide new properties and reactivity that has been known at the research level for a number of years, but lacked an affordable dendrimer to commercialise.
In addition to reduced cost, the new dendrimer family has added benefits such as improved thermal and hydrolytic stability. These are important considerations for handling, shelf-life, shipping and final product stability. Initially, Priostar dendrimers could be used as high-performance additives to address polymer manufacturers’ need for new technologies that can reduce curing times, enable them to process additives into a new formulations, or improve strength and durability.
“These improvements should lead to the evaluation of dendrimers for applications in which dendrimers were previously dismissed-even though they witnessed unique property enhancements,” stated Dr Robert Berry, CEO of DNT. “In addition, Priostar offers the added benefit of new patent life which provides our business partners an opportunity to protect their market sectors. We are aiming to establish a limited number of business partnerships for commercial research that could lead to direct commercialisation.”
|
All News